Page 6 - Wille Finance News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Wille finance. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Wille Finance Today - Breaking & Trending Today

ImmunOs Therapeutics AG Receives Public Funding from Eurostars and Innosuisse for a Novel ...


Press release content from Globe Newswire. The AP news staff was not involved in its creation.
ImmunOs Therapeutics AG Receives Public Funding from Eurostars and Innosuisse for a Novel .
AKAMPIONApril 12, 2021 GMT
- Company forms international consortium with ProteoGenix SAS and Amsterdam UMC
Schlieren (Zurich Area), Switzerland – April 12, 2021 – ImmunOs Therapeutics AG, a Swiss bio-technology company developing a new class of biologics for the treatment of cancer and autoimmune diseases, announced today that is has received public funding from the European Union’s Eurostars-2 Programme and the Swiss Innovation Agency Innosuisse. The funds have been granted for the development of a pioneering HLA-open conformer-specific antibody to treat chronic inflammatory rheumatic diseases. Research will be conducted by a consortium with ProteoGenix SAS (Strasbourg, France) and Amsterdam University Medical Centres (Amsterdam, The Netherlands). ....

Switzerland General , Noord Holland , Marroquin Belaunzaran , Ludger Wess Ines Regina Buth , Philippe Funfrock , Seanr Smith , Schroder Adveq , Vu University Medical Center Vumc , Academic Medical Center , Swiss Innovation Agency Innosuisse , Company Contact , Cardiovascular Sciences , Bioinvest Ltd , Life Sciences Fund , European Union Eurostars , Amsterdam University Medical Centres , Zurich Area , Immunos Therapeutics , European Union , Swiss Innovation Agency , Osiris Marroquin Belaunzaran , Clinical Immunology , Pfizer Ventures , Biomed Partners , Wille Finance , Finvest Ltd ,